Halliburton SEC Filings

Halliburton Company executive share transaction disclosed

A Halliburton Company officer, identified as President - Western Hemisphere, reported a routine share transaction dated December 4, 2025. The filing shows that 7,383 shares of common stock were transferred back to Halliburton to cover federal tax withholding triggered by the vesting of previously granted stock under the company’s Stock and Incentive Plan. The closing price of Halliburton common stock on the New York Stock Exchange on December 2, 2025, when the stock vested, was $26.91.

After this tax-related share transfer, the officer beneficially owned 444,990.607 shares of Halliburton common stock. The report also lists several outstanding stock options to buy Halliburton common stock with exercise prices between $27.14 and $55.68 and expiration dates ranging from January 4, 2026 to December 20, 2028, indicating existing long-term equity incentives.

Halliburton Company executive Sarah I. Rubenfeld, EVP Administration & CHRO, reported routine equity transactions involving Halliburton common stock. On December 4, 2025, 5,840 shares of common stock were transferred to Halliburton to cover federal tax withholding when restricted stock vested under the Stock and Incentive Plan. The vesting relates to stock granted on December 2, 2020, using the New York Stock Exchange closing price of $26.91 on December 2, 2025 for tax purposes. After these tax-related shares were withheld, she beneficially owned 484,831.685 shares directly, including 929.708 shares acquired through the Employee Stock Purchase Plan.

The filing also lists several outstanding stock options, including options to buy 51,100, 34,300, and 30,500 shares at exercise prices of $31.44, $43.38, and $53.54, respectively, with expirations in 2028, 2027, and 2026. A separate option for 44,500 shares at an exercise price of $38.95 expired unexercised on December 2, 2025.

Halliburton Company officer reports tax-related share transfer and option expiration. A Senior Vice President and Treasurer of Halliburton Company reported a Form 4 transaction dated December 4, 2025. The filing shows 658 shares of common stock were transferred to Halliburton to cover federal tax withholding when restrictions lapsed on stock granted under the company’s Stock and Incentive Plan, based on a New York Stock Exchange closing price of $26.91 on December 2, 2025. After this transaction, the officer beneficially owns 77,126 shares of common stock directly. The report also lists several outstanding stock options and notes that an option covering 8,300 shares, originally granted on December 2, 2015, expired on December 2, 2025.

Halliburton Company reported insider stock activity by its EVP, Secretary and Chief Legal Officer. On December 4, 2025, the officer transferred 5,746 shares of common stock to Halliburton at $26.91 per share to cover federal tax withholding tied to restricted stock that vested on December 2, 2025 from a grant made on December 2, 2020. On December 5, 2025, the officer sold 8,854 shares of common stock at $27.89 per share under a pre-arranged Rule 10b5‑1 trading plan adopted on August 13, 2025. After these transactions, the officer directly owned 333,528.49 shares of Halliburton common stock and held an option to buy 54,348 shares at an exercise price of $23.57 per share, exercisable until January 15, 2030.

Halliburton Company executive reports routine tax-related share transfer. The company’s EVP & Chief Financial Officer filed a Form 4 showing that on December 4, 2025, 5,691 shares of Halliburton common stock were transferred to the company to cover federal tax withholding when previously granted restricted stock vested. The shares relate to stock granted on December 2, 2020, which vested on December 2, 2025, when Halliburton’s stock closed at $26.91 on the New York Stock Exchange.

After this transaction, the executive beneficially owns 122,004.771 shares, including 594.394 shares accumulated through dividend reinvestment as of September 30, 2025. The filing also lists multiple stock options to buy Halliburton common stock, with exercise prices ranging from $31.44 to $53.54 and expiration dates between January 4, 2026 and December 5, 2028.

A shareholder of Halliburton plans to sell 8,854 shares of common stock under Rule 144. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $246,938.06. The issuer reports 841,626,610 common shares outstanding, providing context for the size of this planned sale.

The seller acquired these 8,854 shares on 12/02/2025 via restricted stock vesting from the issuer as compensation, and the same date is shown as the payment date. By signing the notice, the seller represents that they are not aware of any material adverse, non-public information about Halliburton’s current or prospective operations.

Halliburton Company announced several leadership changes effective January 1, 2026. The Board appointed Jeffrey Shannon Slocum as Executive Vice President and Chief Operating Officer and expanded the Board from 12 to 13 members, naming him a management director with a term running until the 2026 Annual Meeting of Shareholders. Slocum has held multiple senior roles over more than 20 years at Halliburton, most recently as president, Eastern Hemisphere.

Slocum’s new executive agreement sets a minimum annual base salary of $1,000,000 and provides participation in Halliburton’s key incentive and performance plans, along with severance terms consistent with other top executives. The company also appointed Rami Yassine as President – Eastern Hemisphere, succeeding Slocum, under an executive agreement with a minimum annual base salary of $800,000. Both executives will receive indemnification agreements in line with those provided to other directors and executive officers.

Halliburton Company director files initial ownership report showing no holdings. A reporting person serving as a director of Halliburton Co. (HAL) filed an initial ownership statement for an event dated 12/02/2025. The filing notes that the individual beneficially owns no securities of Halliburton, and there are no non-derivative or derivative holdings listed. This is an administrative disclosure that records the director’s status and confirms that, as of the reported date, the person does not hold Halliburton stock or related derivative securities.

Halliburton Company reported that its Board of Directors increased its size from 11 to 12 members and appointed Timothy A. Leach as a new director, effective immediately. His initial term runs until the 2026 Annual Meeting of Shareholders, or until a successor is elected and qualified.

Leach brings a 40-year oil and gas background, including roles at ConocoPhillips as executive vice president, Lower 48, advisor to the CEO, and as former chairman and chief executive officer of Concho Resources Inc. He will receive standard non‑management director compensation, including an initial restricted stock unit (RSU) equity award of $200,000, with the number of RSUs based on the average closing price of Halliburton common stock in the month before his appointment.

Halliburton also entered into a director indemnification agreement with Leach, providing indemnification and expense advancement to the fullest extent permitted by law. The company issued a press release announcing his appointment, which is furnished as an exhibit.